About MediciNova
MediciNova is a company based in San Diego (United States) founded in 2000 by Yuichi Iwaki.. MediciNova has raised $83.94 million across 5 funding rounds from investors including Sumitomo Mitsui Banking Corporation, CDIB Capital Group and Dr.Ci:Labo. The company has 13 employees as of December 31, 2024. MediciNova has completed 2 acquisitions, including AviGen and Aviagen. MediciNova operates in a competitive market with competitors including TFF Pharmaceuticals, Theravance Biopharma, Elastrin, Chance Pharmaceuticals and ReAlta Life Sciences, among others.
- Headquarter San Diego, United States
- Employees 13 as on 31 Dec, 2024
- Founders Yuichi Iwaki
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medicinova, Inc.
-
Annual Revenue
$0-100as on Dec 31, 2024
-
Net Profit
$-11.05 M-28.91as on Dec 31, 2024
-
EBITDA
$-12.65 M-28.08as on Dec 31, 2024
-
Total Equity Funding
$83.94 M (USD)
in 5 rounds
-
Latest Funding Round
$20 M (USD), Post-IPO
Jan 11, 2021
-
Investors
Sumitomo Mitsui Banking Corporation
& 14 more
-
Employee Count
13
as on Dec 31, 2024
-
Investments & Acquisitions
AviGen
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MediciNova
MediciNova is a publicly listed company on the NASDAQ with ticker symbol MNOV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of MediciNova
MediciNova has successfully raised a total of $83.94M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $20.0M
-
First Round
First Round
(01 Jun 2000)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Post-IPO - MediciNova | Valuation |
investors |
|
| Aug, 2012 | Amount | Post-IPO - MediciNova | Valuation |
investors |
|
| Sep, 2004 | Amount | Series C - MediciNova | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MediciNova
MediciNova has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Sumitomo Mitsui Banking Corporation, CDIB Capital Group and Dr.Ci:Labo. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Sector-agnostic investments are made in early-stage Asia Pacific startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MediciNova
MediciNova has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AviGen and Aviagen. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene therapy products are developed for inherited and acquired diseases.
|
1992 | ||||
|
Poultry breeding stock is supplied globally by Aviagen.
|
1923 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MediciNova
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medicinova Comparisons
Competitors of MediciNova
MediciNova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TFF Pharmaceuticals, Theravance Biopharma, Elastrin, Chance Pharmaceuticals and ReAlta Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of inhalation products for chronic respiratory diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory and immunological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic targets related to arterial and lung diseases
|
|
| domain | founded_year | HQ Location |
Inhalation therapies for pulmonology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs for acute inflammatory and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medicinova
Frequently Asked Questions about MediciNova
When was MediciNova founded?
MediciNova was founded in 2000.
Where is MediciNova located?
MediciNova is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of MediciNova?
Yuichi Iwaki is the current CEO of MediciNova. They have also founded this company.
Is MediciNova a funded company?
MediciNova is a funded company, having raised a total of $83.94M across 5 funding rounds to date. The company's 1st funding round was a Series C of $44.82M, raised on Jun 01, 2000.
How many employees does MediciNova have?
As of Dec 31, 2024, the latest employee count at MediciNova is 13.
What does MediciNova do?
MediciNov is a biopharmaceutical company that develops novel, small-molecule therapeutics for the treatment of diseases with unmet needs. It holds rights to a diversified portfolio of clinical and preclinical product candidates. Their pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, COPD exacerbations, multiple sclerosis, and other neurologic conditions, asthma, interstitial cystitis, solid tumor cancers, Generalized Anxiety Disorder, preterm labor, and urinary incontinence and two preclinical-stage compounds for the treatment of thrombotic disorders. Focusing on its two prioritized product candidates, MN-221, for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease exacerbations, and ibudilast (MN-166AV411).
Who are the top competitors of MediciNova?
MediciNova's top competitors include TFF Pharmaceuticals, Theravance Biopharma and ReAlta Life Sciences.
Is MediciNova publicly traded?
Yes, MediciNova is publicly traded on NASDAQ under the ticker symbol MNOV.
How many acquisitions has MediciNova made?
Who are MediciNova's investors?
MediciNova has 15 investors. Key investors include Sumitomo Mitsui Banking Corporation, CDIB Capital Group, Dr.Ci:Labo, 3D Investment Partners, and Aspire Capital.
What is MediciNova's ticker symbol?
The ticker symbol of MediciNova is MNOV on NASDAQ.